This site is intended for healthcare professionals only
LoginRegister
Bristol Myers Squibb Approaches SC to Halt Zydus Biosimilar Nivolumab SaleBristol Myers Approaches SC to Halt Zydus' Biosimilar Nivolumab Sale
Antibiotic Killmed 625 LB Fails Quality Test, No Clavulanic Acid Found, Declared Seriously SubstandardCentre Sets Minimum Import Price for Key Antibiotic APIs Penicillin G, Amoxicillin, 6-APA
AstraZeneca to Invest USD 15 Billion in China by 2030AstraZeneca to Invest USD 15 Billion in China by 2030
Dr. Reddys Labs Bags Health Canada Nod for Ozempic Generic, OneSource to Scale SupplyDr Reddy's Russia Arm Slapped Rs 2.45 Cr VAT Penalty
Pune FDA Crackdown: 102 Chemist Licences Cancelled, 286 Suspended Over Drug Law ViolationsIndia-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and Devices
Punjab Shocker: Chemist Murdered for Refusing to Pay Rs 50 Lakh Extortion DemandPunjab Shocker: Chemist Murdered for Refusing to Pay Rs 50 Lakh Extortion Demand
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchUSFDA Grants Orphan Drug Status to Shilpa-mAbTree Biologic for Rare Blood Cancers
Caplin Steriles Secures USFDA Nod for Generic DEPO-MEDROL InjectionCaplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection
Prior Intimation System Under NDCT Rules Wont Apply to Hormones, Cytotoxics, Beta-Lactams, Certain Biologics: CDSCOHealth Ministry Reduces Clinical Trial Approval Time from 90 to 45 Days
India-EU Free Trade Agreement Opens USD 572 Billion Pharma, MedTech Market for Indian IndustryIndia-EU Free Trade Agreement Opens USD 572 Billion Pharma, MedTech Market for Indian Industry
CDSCO Clears Eyestems Phase II Trial for Stem Cell Therapy Eyecyte-RPE in Dry AMDCDSCO Clears Eyestem's Phase II Trial for Stem Cell Therapy Eyecyte-RPE in Dry AMD
Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss EntryRoche's Experimental Obesity Drug Delivers Up to 22.5% Weight Loss in Phase-II Trial
X